Sangamo Therapeutics
SGMO
#10545
Rank
โ‚น2.92 B
Marketcap
โ‚น7.05
Share price
0.00%
Change (1 day)
-81.72%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น7.52 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚น7.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น6.64 B-1.8%
2024-12-31โ‚น6.76 B-1.41%
2023-12-31โ‚น6.86 B-69%
2022-12-31โ‚น22.13 B-14.17%
2021-12-31โ‚น25.79 B-20.05%
2020-12-31โ‚น32.26 B120.95%
2019-12-31โ‚น14.60 B-6.41%
2018-12-31โ‚น15.60 B147.22%
2017-12-31โ‚น6.31 B328.06%
2016-12-31โ‚น1.47 B-10.53%
2015-12-31โ‚น1.64 B-28.92%
2014-12-31โ‚น2.31 B96.18%
2013-12-31โ‚น1.18 B22.37%
2012-12-31โ‚น0.96 B153.4%
2011-12-31โ‚น0.38 B19.92%
2010-12-31โ‚น0.31 B-56.26%
2009-12-31โ‚น0.72 B21.36%
2008-12-31โ‚น0.59 B29.5%
2007-12-31โ‚น0.46 B47.51%
2006-12-31โ‚น0.31 B-37.65%
2005-12-31โ‚น0.50 B394.27%
2004-12-31โ‚น0.10 B42.16%
2003-12-31โ‚น71.52 M-24.71%
2002-12-31โ‚น94.99 M-26.21%
2001-12-31โ‚น0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น11.406 T 151,582.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.938 T 105,467.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.032 T 13,624.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น4.099 T 54,407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.129 T 41,520.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น7.885 T 104,758.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น386.32 B 5,037.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น226.68 B 2,914.33%๐Ÿ‡บ๐Ÿ‡ธ USA